MS Drug Treatments

In accordance to the right of information under the Freedom of Information Act 2000 I am writing to request the following information.
Number of patients with an annual review in the last 12 months and number of patients with an MRI in the last 12 months being treated with the following products:
• Tysabri
• Gilenya
• Interferon beta 1a
• Interferon beta 1b
• Copaxone
• Lemtrada
• Tecfidera
• Aubagio
• Plegridy
The Pharmacy stock control system used by the Royal Surrey County Hospital NHS Foundation Trust is unable to align patients with drugs dispensed and whether they have had an annual review or an MRI in the last 12 months.

I would also like to request the following information on patient numbers:
• Number of new MS diagnoses
• Number of patients who have had a relapse in the above month
• Number of relapse events in the above month
I would like this information for the period March 2015 to February 2016, broken down by month and provided to me electronically in the spread sheet provided. To extrapolate this information the Trust would need to review individual healthcare records and, therefore, the cost of compliance would exceed the appropriate limit under Section 12 of the Freedom of Information Act.

©2017 Royal Surrey County Hospital

Log in with your credentials

or    

Forgot your details?